EP2397155
Methods and compositions for the treatment of persistent infections by inhibiting the programmed cell death 1 (PD-1)pathway
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
8.6.2006EP published:
13.12.2017EP application number:
11162667.7
EPO information:
European Patent Register
Max expiry date:
7.6.2026
Title:
Methods and compositions for the treatment of persistent infections by inhibiting the programmed cell death 1 (PD-1)pathway
Timeline
Today
8.6.2006EP application
13.12.2017EP Publication
Owner
Name:
Dana-Farber Cancer Institute, Inc.Address:
450 Brookline Avenue, 02215, Boston, MA, US
Name:
The Brigham and Women's Hospital, Inc.Address:
75 Francis Street, 02115, Boston, MA, US
Name:
Emory UniversityAddress:
1599 Clifton Road NE 4th Floor, 30322, Atlanta, GA, US
Name:
President and Fellows of Harvard CollegeAddress:
17 Quincy Street, 02138, Cambridge, MA, US
Inventor
Name:
Freeman, GordanAddress:
Brookline, MA, US
Name:
Sharpe, ArleneAddress:
Brookline, MA, US
Name:
Dorfman, David M.Address:
Brookline, MA, US
Name:
Ahmed, RafiAddress:
Atlanta, GA, US
Name:
Barber, DanielAddress:
North Bethesda, MD, US
Name:
Wherry, E. JohnAddress:
Havertown, Pennsylvania, US
Priority
Number:
688872 PDate:
8.6.2005Country:
US
Classification
Categories:
A61K 39/00, A61P 31/12, A61P 31/18, A61P 31/22, G01N 33/53, C07K 16/28